Obesity is a risk factor for chronic kidney disease, and its prevalence among the elderly is increasing. We investigated the effects of changes in body fat percentage (BFP) on the longitudinal changes in the estimated glomerular filtration rate (eGFR) in the elderly. This prospective cohort study included 390 participants aged >65 years who underwent bioelectrical impedance analysis at baseline and follow-up as a part of the Korean Longitudinal Study on Health and Aging. After a median follow-up period of 5.3 years, BFP was significantly higher than that at the start point (P<0.05). Participants who had the largest increase in BFP had the highest BMI and waist circumference (WC) (P<0.001). The highest tertile had the highest white blood cell count and erythrocyte sedimentation rate, incidence of rapid progression, and decline in eGFR >25% (P≤0.017, P = 0.025, P = 0.005, respectively). The lowest tertile had the lowest triglyceride and highest high-density lipoprotein levels (P<0.05). The adjusted decline rate in eGFR was correlated with a change in BFP (P = 0.039), but not with that in BMI or WC. The highest tertile had a 4.875-fold increase in the risk for rapid progression to a decline in eGFR (95% CI: 1.366–17.397) and a 4.931-fold decrease in the risk to a decline in eGFR>25% (95% CI: 1.617–15.037), when compared with the lowest tertile. In subgroup analysis, the incidence of renal outcomes was significantly increased according to the increase in BFP in patients with lower eGFR (P≤0.010). A change in BFP may be associated with inflammation and dyslipidemia development, and longitudinal changes in body fat are related to a decrease in eGFR in the elderly.
References
[1]
Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, et al. (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363: 2211–2219.
[2]
Prospective Studies Collaboration (2009) Whitlock G, Lewington S, Sherliker P, Clarke R, et al. (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373: 1083–1096.
[3]
Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, et al. (2004) Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65: 1870–1876.
[4]
Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS (2006) Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21–28.
[5]
Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, et al. (2006) Obesity and risk for chronic renal failure. J Am Soc Nephrol 17: 1695–1702.
[6]
Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ (2008) Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 73: 19–33.
[7]
Jee SH, Sull JW, Park J, Lee SY, Ohrr H, et al. (2006) Body-mass index and mortality in Korean men and women. N Engl J Med 355: 779–787.
[8]
Corrada MM, Kawas CH, Mozaffar F, Paganini-Hill A (2006) Association of Body Mass Index and Weight Change with All-Cause Mortality in the Elderly. Am J Epidemiol 163: 938–949.
[9]
Reuser M, Bonneux L, Willekens F (2008) The burden of mortality of obesity at middle and old age is small: a life table analysis of the US Health and Retirement Survey. Eur J Epidemiol 23: 601–607.
[10]
Bender R, J？ckel KH, Trautner C, Spraul M, Berger M (1999) Effect of age on excess mortality in obesity. JAMA 281: 1498–1504.
[11]
Dey DK, Rothenberg E, Sundh V, Bosaeus I, Steen B (2001) Body mass index, weight change and mortality in the elderly: a 15 y longitudinal population study of 70 y olds. Eur J Clin Nutr 55: 482–492.
[12]
Diehr P, O'Meara ES, Fitzpatrick A, Newman AB, Kuller L, et al. (2008) Weight, mortality, years of healthy life, and active life expectancy in older adults. J Am Geriatr Soc 56: 76–83.
[13]
Grabowski DC, Ellis JE (2001) High body mass index does not predict mortality in older people: an analysis of the Longitudinal Study of Aging. J Am Geriatr Soc 49: 968–979.
[14]
Kramer H, Shoham D, McClure LA, Durazo-Arvizu R, Howard G, et al. (2011) Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis 58: 177–185.
[15]
Ricks J, Molnar MZ, Kovesdy CP, Kopple JD, Norris KC, et al. (2011) Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients. Am J Kidney Dis 58: 574–582.
[16]
Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303: 235–241.
[17]
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038–2047.
[18]
Gába A, P？idalová M (2013) Age-related changes in body composition in a sample of Czech women aged 18–89 years: a cross-sectional study. Eur J Nutr In press.
[19]
Villareal DT, Apovian CM, Kushner RF, Klein S (2005) American Society for Nutrition, (2005) et al. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr 82: 923–934.
[20]
Baumgartner RN, Stauber PM, McHugh D, Koehler KM, Garry PJ (1995) Cross-sectional age differences in body composition in persons 60+ years of age. Gerontol A Biol Sci Med Sci 50: M307–M316.
[21]
Han SS, Kim KW, Na KY, Chae DW, Kim YS, et al. (2009) Quality of life and mortality from a nephrologist's view: a prospective observational study. BMC Nephrol 10: 39.
[22]
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al. (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612.
[23]
National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1–S266.
[24]
International Association for the Study of Obesity (IASO) World map of obesity. Available: http://www.iaso.org/resources/world-map-？obesity/. Accessed 2013 December 1.
[25]
Elia M, Ritz P, Stubbs RJ (2000) Total energy expenditure in the elderly. Eur J Clin Nutr 54: S92–S103.
[26]
Tzankoff SP, Norris AH (1977) Effect of muscle mass decrease on age-related BMR changes. J Appl Physiol 43: 1001–1006.
[27]
Williamson DF, Madans J, Anda RF, Kleinman JC, Kahn HS, et al. (1993) Recreational physical activity and ten-year weight change in a US national cohort. Int J Obes Relat Metab Disord 17: 279–286.
[28]
Corpas E, Harman SM, Blackman MR (1993) Human growth hormone and human aging. Endocr Rev 14: 20–39.
[29]
Matsumoto AM (2002) Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 57: M76–M99.
[30]
Zoccali C, Torino C, Tripepi G, Mallamaci F (2012) Assessment of obesity in chronic kidney disease: what is the best measure? Curr Opin Nephrol Hypertens 2: 641–646.
[31]
Yamashita K, Kondo T, Osugi S, Shimokata K, Maeda K, et al. (2012) The significance of measuring body fat percentage determined by bioelectrical impedance analysis for detecting subjects with cardiovascular disease risk factors. Circ J 76: 2435–2442.
[32]
Tamba S, Nakatsuji H, Kishida K, Noguchi M, Ogawa T, et al. (2010) Relationship between visceral fat accumulation and urinary albumin-creatinine ratio in middle-aged Japanese men. Atherosclerosis 211: 601–605.
[33]
Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59: 1498–1509.
[34]
Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE (2001) Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12: 1211–1217.
[35]
Ramkumar N, Cheung AK, Pappas LM, Roberts WL, Beddhu S (2004) Association of obesity with inflammation in chronic kidney disease: a cross-sectional study. J Ren Nutr 14: 201–207.
[36]
Carvalho LK, Barreto Silva MI, da Silva Vale B, Bregman R, Martucci RB, et al. (2012) Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients Stages 3 and 4: a longitudinal study. Nephrol Dial Transplant 27: 1423–1428.
[37]
de Boer IH, Katz R, Fried LF, Ix JH, Luchsinger J, et al. (2009) Obesity and change in estimated GFR among older adults. Am J Kidney Dis 54: 1043–1051.
[38]
Hamdy O, Porramatikul S, Al-Ozairi E (2006) Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2: 367–373.
[39]
Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, et al. (2011) Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension 58: 784–790.
[40]
Lukaski HC, Bolonchuk WW, Hall CB, Siders WA (1986) Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 60: 1327–1332.
